WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients. Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday. So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses. “It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.” |
Ethnic army seizes city on MyanmarAustralian town of Marble Bar clocks 26 consecutive days over 43 degrees CelsiusUK economy fell into recession as people cut spendingKenneth Eugene Smith: Alabama carries out first US nitrogen gas executionAustralian town of Marble Bar clocks 26 consecutive days over 43 degrees CelsiusClimate activists demand Christchurch include cruise ship emissions in targetsForeign Affairs Minister Winston Peters praises US engagement in the PacificTrump seeks Supreme Court pause in 2020 election caseTaiwan's remaining Pacific allies pledge supportIn China, a factory is turning old wedding photographs into fuel